Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer immunotherapy
4
×
life sciences
medicare
4
×
national
national blog main
national top stories
new york blog main
4
×
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
deals
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aduro biotech
alzheimer's disease
biogen
celgene
drug prices
fda
gene therapy
What
companies
4
×
bio
roundup
drug
ipo
life
new
price
science
week
alzheimer’s
approval
arena’s
arrival
biogen’s
biopharmaceutical
biotech
bounty
cig
comeback
convo
corner
days
deals
delivered
different
earlier
expressing
fail
failures
gene
hasn’t
increases
industry
ipos
latest
littered
little
market
moderna’s
Language
unset
Current search:
medicare
×
companies
×
" cancer immunotherapy "
×
" new york blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More